Maxcyte (MXCT) Change in Acquisitions & Divestments (2020 - 2026)

Maxcyte (MXCT) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $28.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 39.91% year-over-year to $28.0 million; the TTM figure through Mar 2026 stood at $137.2 million (down 20.06% YoY), while the FY2025 annual figure was $155.8 million, down 2.31% from the prior year.
• Change in Acquisitions & Divestments fell to $28.0 million in Q1 2026 per MXCT's latest filing, from $38.2 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $200.8 million in Q1 2022 and bottomed at $6.5 million in Q2 2022.
• Historically, Change in Acquisitions & Divestments has averaged $55.4 million across 5 years, with a median of $43.0 million in 2024.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments surged 1154.97% — and 2024, when it sank 61.29%.
• Maxcyte's Change in Acquisitions & Divestments stood at $52.5 million in 2022, then increased by 26.19% to $66.2 million in 2023, then plunged by 53.21% to $31.0 million in 2024, then rose by 23.1% to $38.2 million in 2025, then fell by 26.63% to $28.0 million in 2026.
• Business Quant data shows MXCT's Change in Acquisitions & Divestments at $28.0 million in Q1 2026, $38.2 million in Q4 2025, and $40.0 million in Q3 2025.